Endogenous ghrelin increases in adriamycin-induced heart failure rats

Journal of Endocrinological Investigation

Volumn 30, Issue 2, 2007, Pages 117-125

  Xu, Z ^a   Wu, Wo ^a   Zhang, X ^a   Liu, G ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adriamycin; Apoptosis; Ghrelin; Heart failure; Mitochondria; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; DOXORUBICIN; GHRELIN; MALONALDEHYDE; PHOSPHATE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DISEASE COURSE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; RADIOIMMUNOASSAY; RAT;

EID: 34247200939     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347409     Document Type: Article

References (35)

1. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990, 40: 355-67.
2. Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001, 104: 2034-8.
3. Nagaya N, Uematsu M, Kojima M, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001, 104: 1430-5.
4. Zhao M, Wu W, Duan X, et al. The protective effects of sini decoction on mitochondrial function in adriamycin-induced heart failure rats. Zhong Yao Cai 2005, 28: 486-9.
5. Yang S, Zheng R, Hu S, et al. Mechanism of cardiac depression after trauma-hemorrhage: increased ardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function. Am J Physiol Heart Circ Physiol 2004, 287: H2183-91.
6. Hallstrom S, Gasser H, Neumayer C, et al. S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 2002, 105: 3032-8.
7. Murfitt RR, Stiles JW, Powell WJ Jr, Sanadi DR. Experimental myocardial ischemia characteristics of isolated mitochiondrial subpopulations. J Mol Cell Cardiol 1978, 10: 109-23.
8. Marklund SL. Pyrogallol autooxidation. In: Greenwald RA ed. Handbook of methods for oxygen radical research. Boca Raton, Fla: CRC Press. 1985, 243-7.
9. Geller BL, Winge DR. A method for distinguishing Cu, Zn-and Mn-containing superoxide dismutases. Anal Biochem 1983, 128: 86-92.
10. Singal PK, Pierce GN. Adriamycin stimulates low-affinity Ca21 binding and lipid peroxidation but depresses myocardial function. Am J Physiol 1986, 250: H41925.
11. Flameng W, Borgers M, Daenen W, Stalpaert G. Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man. J Thorac Cardiovasc Surg 1980, 79: 413-24.
12. Tong J, Ganguly PK, Singal PK. Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am J Physiol 1991, 260: H909-16.
13. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656-60.
14. Garcia EA, Korbonits M. Ghrelin and cardiovascular health. Curr Opin Pharmacol 2006, 6: 142-7.
15. Akashi YJ, Springer J, Anker SD. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep 2005, 2: 198-203.
16. Nagaya N, Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure. Regul Pept 2003, 14: 71-7.
17. Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004, 110: 3674-9.
18. Nagaya N, Miyatake K, Uematsu M, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab 2001, 86: 5854-9.
19. Broglio F, Prodam F, Riganti F, Muccioli G, Ghigo E. Ghrelin: from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions. Front Horm Res 2006, 35: 102-14.
20. Iglesias MJ, Pineiro R, Blanco M, et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004, 62: 481-8.
21. Garcia JM, Garcia-Touza M, Hijazi RA, et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 2005, 90: 2920-6.
22. Akashi YJ, Springer J, Anker SD. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep 2005, 2: 198-203.
23. Filippatos GS, Anker SD, Kremastinos DT. Pathophysiology of peripheral muscle wasting in cardiac cachexia. Curr Opin Clin Nutr Metab Care 2005, 8: 249-54.
24. Barazzoni R, Bosutti A, Stebel M, et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab 2005, 288: E228-35.
25. Omerovic E, Bollano E, Basetti M, et al. Bioenergetic, functional and morphological consequences of postinfarct cardiac remodeling in the rat. J Mol Cell Cardiol 1999, 31: 1685-95.
26. Beer M, Seyfarth T, Sandstede J, et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 2002, 40: 1267-74.
27. Kawasaki N, Lee JD, Shimizu H, Ueda T. Long-term 1-carnitine treatment prolongs the survival in rats with adriamycin-induced heart failure. J Card Fail 1996, 2: 293-9.
28. Vogt AM, Kubler W. Heart failure: is there an energy deficit contributing to contractile dysfunction? Basic Res Cardiol 1998, 93: 1-10.
29. McMurray JJ, Pfeffer MA. Heart failure. Lancet 2005, 305: 1877-89.
30. Li T, Danelisen I, Bello-Klein A, Singal PK. Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc Res 2000, 46: 523-30.
31. Choi KS, Tappel AL. In activation of ribonuclease and other enzymes by peroxidizing lipids and by malonaldehyde. Biochemistry 1969, 8: 2827-32.
32. Asimakis GK, Lick S, Patterson C. Postischemic recovery of contractile function is impaired in SOD2(+/-) but not SOD1(+/-) mouse hearts. Circulation 2002, 105: 981-6.
33. Chang L, Ren Y, Liu X, et al. Protective effects of ghrelin on ischemia/ reperfusion injury in the isolated rat heart. J Car diovasc Pharmacol 2004, 43: 165-70.
34. Li WG, Gavrila D, Liu X, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004, 109: 2221-6.
35. Taegtmeyer H. Genetics of energetics: transcriptional responses in cardiac metabolism. Ann Biomed Eng 2000, 28: 871-6.